{
    "Trade/Device Name(s)": [
        "Dochek\u00ae Multi-Drug Urine Test Dipcard Rx",
        "Dochek\u00ae Multi-Drug Urine Test Dipcard"
    ],
    "Submitter Information": "Guangzhou Decheng Biotechnology Co., Ltd.",
    "510(k) Number": "K240698",
    "Predicate Device Reference 510(k) Number(s)": [
        "K232659"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "NFT",
        "DKZ",
        "PTH",
        "DIS",
        "NGL",
        "NFV",
        "JXM",
        "NFY",
        "DIO",
        "PTG",
        "DJR",
        "NGG",
        "DJC",
        "NGM",
        "LCM",
        "QBF",
        "JXN",
        "QAW",
        "LFG",
        "NFW",
        "LDJ"
    ],
    "Summary Letter Date": "March 14, 2024",
    "Summary Letter Received Date": "March 14, 2024",
    "Submission Date": "May 9, 2024",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3150",
        "21 CFR 862.3650",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3620",
        "21 CFR 862.3610",
        "21 CFR 862.3700",
        "21 CFR 862.3910",
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System",
        "Barbiturate Test System",
        "Opiate Test System",
        "Benzodiazepine Test System",
        "Cocaine and cocainemetabolite test system",
        "Methadone Test System",
        "Methamphetamine Test System",
        "Propoxyphene test system",
        "Tricyclic antidepressant drugs test system",
        "Cannabinoids Test System"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Amphetamine (AMP)",
        "Secobarbital (BAR)",
        "Buprenorphine (BUP)",
        "Oxazepam (BZO)",
        "Cocaine (COC)",
        "2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)",
        "Methylenedioxymethamphetamine (MDMA)",
        "Methamphetamine (MET)",
        "Morphine (MOP/OPI)",
        "Methadone (MTD)",
        "Oxycodone (OXY)",
        "Phencyclidine (PCP)",
        "Propoxyphene (PPX)",
        "Nortriptyline (TCA)",
        "Cannabinoids (THC)",
        "6-Monoacetylmorphine (6-MAM)"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        "Immunoassay",
        "Lateral flow",
        "Immunochromatographic assay",
        "Competitive binding",
        "Antigen-antibody reaction"
    ],
    "Methodologies": [
        "Immunochromatographic lateral flow competitive binding assay"
    ],
    "Submission Type(s)": [
        "Dipcard",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Dochek Multi-Drug Urine Test Dipcard Rx and Dochek Multi-Drug Urine Test Dipcard for qualitative screening of multiple drugs in human urine by immunochromatographic lateral flow assay.",
    "Indications for Use Summary": "Qualitative screening for single or multiple drugs of abuse in human urine for prescription or over-the-counter use; results are preliminary and require confirmatory testing by GC/MS or LC/MS.",
    "fda_folder": "Toxicology"
}